| Literature DB >> 33816548 |
Hsin-Hsin Huang1, Chien-Han Tsao2,3, James Cheng-Chung Wei1,3,4.
Abstract
Objectives: Removal of part of the tongue base, in combination with uvulopharyngopalatoplasty via transoral robotic surgery (TORS), for treating obstructive sleep apnea syndrome (OSAS) results in enlargement of the oropharynx and hypopharynx and change in the size of the resonance chamber. These procedures may also alter the laryngeal-hyoid bone complex, which is linked to vocal fold tension. Thus, there is the potential for change in phonation and pitch after surgery. Study Design: Prospective, nonrandomized, institutional board-approved study.Entities:
Keywords: multi-dimensional voice program; pitch; real time pitch program; semitone; transoral robotic surgery; voice handicap index-10
Year: 2021 PMID: 33816548 PMCID: PMC8011657 DOI: 10.3389/fsurg.2021.647792
Source DB: PubMed Journal: Front Surg ISSN: 2296-875X
Figure 1Musical note and scale to frequency chart. According to an electronic keyboard played from left to right in a standard soundproof room with multi-dimensional voice analysis software to measure and obtain the corresponding frequency, retaining all decimal points.
Figure 2Surgical range on base of tongue.
Demographic data of OSA patients.
| Age (years) | 46.48 ± 11.37 |
| Sex (F) | 15 (2) |
| Smoking (%) | 6 (40%) |
| Drinking (%) | 1 (6.6%) |
| Obesity | 13 (86.6%) |
| Hypertension (%) | 13 (86.6%) |
| Diabetis mellitus | 3 (20%) |
| Hyperlipidermia | 8 (53.3%) |
| Obstructive sleep apnea | 15 |
| Mild | 1(6.6%) |
| Moderate | 3(20%) |
| Severe | 11(30) |
Expressed as a numerical value (percentage) or average ± standard deviation.
Obesity: body mass index BMI value = 27 kg / m.
All diabetic patients suffered from type 2 diabetes.
Hyperlipidemia: total serum cholesterol level ≥200 mg / dl, triglyceride level (serum triglyceride level) ≥200 mg / d or taking drugs to control blood lipids.
Obstructive sleep apnea: defined as sleep disordered breathing index (AHI, apnoea-hypopnoea index) ≥ 5.
Differences in sleep parameters before and after TORS.
| Age (years) | 46.48 ± 11.37 | ||
| Sex (male %) | 25(30) | ||
| BMI (kg/m2) | 27.52 ± 3.60 | 27.34 ± 2.926 | 0.519 |
| Polysomnography (PSG) | |||
| Apnea-hyponea index (AHI, events/h) | 51.54± 25.29 | 34.31 ± 22.80 | 0.000 |
| Total sleep time, (h) | 8.86 ± 1.73 | 7.34 ± 2.03 | 0.911 |
| Sleep efficiency, (%) | 88.87 ± 8.49 | 90.28 ± 7.817 | 0.442 |
| Sleep latency, (min) | 114.54 ± 57.39 | 103.43 ± 43.92. | 0.411 |
| Sleep architecture, (% of total sleep time) | |||
| Rapid eye movement (REM, %) | 17.72 ± 7.00 | 18.80 ± 6.23 | 0.453 |
| Stage 1 sleep, (%) | 27.42 ± 17.03 | 21.66 ± 15.66 | 0.040 |
| Stage 2 sleep, (%) | 58.32 ± 12.85 | 53.11 ± 17.55 | 0.139 |
| Stage 3 sleep, (%) | 1.08 ± 2.46 | 1.27 ± 4.11 | 0.830 |
| Stage 4 sleep, (%) | 0.00 ± 0.00 | 0.00 ± 0.00 | |
| Arousal index, (event/h) | 33.36 ± 21.29 | 30.18 ± 20.47 | 0.426 |
| Oxygen desaturation index (ODI, event/h) | 44.22 ± 26.06 | 24.15 ± 22.04 | 0.000 |
| Longest apnea time, (s) | 48.70 ± 17.23 | 41.09 ± 25.22 | 0.142 |
| Mean SaO2, (%) | 91.74 ± 15.97 | 94.09 ± 2.13 | 0.43 |
| Lowest SaO2, (%) | 73.50 ± 11.42 | 80.57 ± 9.70 | 0.000 |
| Snoring index, (events/h) | 444.56 ± 101.61 | 366.51 ± 146.42 | 0.008 |
BMI, Body mass index; PSG, Polysomnography; AHI, Apnea Hypopnea Index; REM: Rapid eye movement; ODI, Oxygen desaturation index.
Surgical results for different AHI.
| Cured | AHI <5 and ESS <10 and >50% reduction | 2/15 (6.6%) | 6.6% |
| No need to use CPAP | AHI <15 and ESS <10 and >50% reduction | 5/15 (33.3%) | 39.9% |
| Success | AHI <20 and ESS <10 and >50% reduction (reduction/elimination of excessive daytime somnolence and cardiovascular risk factors) | 4/15 (26.6%) | 66.5% |
| Failure | AHI >20 and any ESS value and <50% reduction (no real clinical improvement) | 4/15 (26.6%) | 26.6% |
Comparisons of acoustic parameters, common pitch, and VHI-10 scale, pre and post TORS for OSAS.
| Fo (Hz) | 141.53 ± 28.73 | 135.56 ± 35.51 | 0.553 |
| MFo (Hz) | 139.01 ± 27.63 | 133.13 ± 34.20 | 0.540 |
| PPQ (%) | 2.00 ± 0.54 | 2.31 ± 0.62 | 0.389 |
| Jitter (%) | 3.18 ± 0.80 | 3.62 ± 0.98 | 0.381 |
| Shimmer (%) | 7.58 ± 3.22 | 10.83 ± 2.81 | 0.080 |
| APQ (%) | 8.49 ± 4.65 | 12.86 ± 3.71 | 0.145 |
| NHR (%) | 0.20 ± 0.55 | 0.26 ± 0.41 | 0.093 |
| VTI | 0.23 ± 0.33 | 0.16 ± 0.25 | 0.251 |
| SPI | 24.87 ± 4.78 | 24.39 ± 3.27 | 0.776 |
| Lowest pitch (Hz) | 117.45 ± 30.45 | 131.42 ± 48.44 | 0.334 |
| Highest pitch (Hz) | 353.18 ± 161.92 | 387.99 ± 143.59 | 0.167 |
| Pitch range (Hz) | 235.72 ± 156.70 | 256.57 ± 104.30 | 0.449 |
| Lowest note | 1.57 ± 1.51 | 2.57 ± 3.74 | 0.281 |
| Highest note | 15.7 ± 8.90 | 18.7 ± 5.74 | 0.156 |
| Note grade range | 14.14 ± 8.23 | 16.14 ± 3.76 | 0.386 |
| VHI 10 | 7 ± 7.37 | 8 ± 8.52 | 0.742 |
Wilcoxon signed rank test. All parameter values in the table are expressed as mean ± standard deviation. Fo(Hz), Average fundamental frequency; MFo, Mean fundamental frequency; PPQ, Pitch period perturbation quotient; Jitter, Jitter percent; Shimmer, Shimmer percent; APQ, Amplitude Perturbation Quotient, NHR, Noise to Harmonic Ratio; VTI, Voice turbulence index; SPI, Soft phonation index; RAP, Relative Average Perturbation.
Correlation of VHI-10 score with pitch and sound parameters.
| Fo (Hz) | −0.424 | 0.344 |
| MFo (Hz) | −0.461 | 0.297 |
| PPQ (%) | −0.331 | 0.468 |
| Jitter (%) | −0.517 | 0.235 |
| Shimmer (%) | −0.311 | 0.498 |
| APQ (%) | −0.276 | 0.549 |
| NHR (%) | −0.034 | 0.943 |
| VTI | 0.115 | 0.806 |
| SPI | −0.425 | 0.342 |
| Lowest pitch (Hz) | −0.457 | 0.799 |
| Highest pitch (Hz) | −0.297 | 0.518 |
| Pitch range (Hz) | −0.020 | 0.996 |
| Lowest note | −0.808 | 0.028 |
| Highest note | −0.040 | 0.932 |
| Note grade range | 0.285 | 0.536 |
Spearman's rho test.